Cargando…

Nonalcoholic fatty liver disease: Evolving paradigms

In the last years new evidence has accumulated on nonalcoholic fatty liver disease (NAFLD) challenging the paradigms that had been holding the scene over the previous 30 years. NAFLD has such an epidemic prevalence as to make it impossible to screen general population looking for NAFLD cases. Conver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lonardo, Amedeo, Nascimbeni, Fabio, Maurantonio, Mauro, Marrazzo, Alessandra, Rinaldi, Luca, Adinolfi, Luigi Elio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643282/ https://www.ncbi.nlm.nih.gov/pubmed/29085206 http://dx.doi.org/10.3748/wjg.v23.i36.6571

Ejemplares similares

NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk
por: Ballestri, Stefano, et al.
Publicado: (2017)

Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease
por: Ballestri, Stefano, et al.
Publicado: (2021)

Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease?
por: Nascimbeni, Fabio, et al.
Publicado: (2018)

History of Nonalcoholic Fatty Liver Disease
por: Lonardo, Amedeo, et al.
Publicado: (2020)

Can metabolomic signature foster precision medicine approaches in nonalcoholic fatty liver disease arena?
por: Lonardo, Amedeo
Publicado: (2022)

Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight
por: Ballestri, Stefano, et al.
Publicado: (2016)

Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications
por: Lonardo, Amedeo, et al.
Publicado: (2022)

Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
por: Lonardo, Amedeo, et al.
Publicado: (2016)

Pediatric nonalcoholic fatty liver disease – a changing diagnostic paradigm
por: Trandafir, Laura Mihaela, et al.
Publicado: (2020)

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
por: Mantovani, Alessandro, et al.
Publicado: (2021)

Portal Hypertension in Nonalcoholic Fatty Liver Disease: Challenges and Paradigms
por: Mitten, Emilie K., et al.
Publicado: (2023)

Association of Nonalcoholic Fatty Liver Disease (NAFLD) with Peripheral Diabetic Polyneuropathy: A Systematic Review and Meta-Analysis
por: Greco, Carla, et al.
Publicado: (2021)

Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis
por: Rinaldi, Luca, et al.
Publicado: (2017)

The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart
por: Dogru, Teoman, et al.
Publicado: (2021)

Methodological Tools for Exploring Novel Biopharmaceutical Approaches to the Metabolic Syndrome and Related Disorders: A Commentary on: Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. A Focus on Early Phase Clinical Drug Development, Second Edition
por: Lonardo, Amedeo, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure
por: Valbusa, Filippo, et al.
Publicado: (2016)

Dietary Anthocyanins as Nutritional Therapy for Nonalcoholic Fatty Liver Disease
por: Valenti, Luca, et al.
Publicado: (2013)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
por: Arrese, Marco, et al.
Publicado: (2021)

Insights into the evolving role of the gut microbiome in nonalcoholic fatty liver disease: rationale and prospects for therapeutic intervention
por: Mouzaki, Marialena, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease and cardiovascular disease phenotypes
por: Bisaccia, Giandomenico, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease stratification by liver lipidomics
por: Vvedenskaya, Olga, et al.
Publicado: (2021)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013)

Sirtuins and nonalcoholic fatty liver disease
por: Nassir, Fatiha, et al.
Publicado: (2016)

Nonalcoholic fatty liver disease and diabetes
por: Bellini, Maria Irene, et al.
Publicado: (2022)

Portal Hypertension in Nonalcoholic Fatty Liver Disease: From Pathogenesis to Clinical Practice
por: Nababan, Saut Horas H., et al.
Publicado: (2022)

Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?
por: Adinolfi, Luigi Elio, et al.
Publicado: (2018)

Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?
por: Mantovani, Alessandro, et al.
Publicado: (2016)

Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Buzzetti, Elena, et al.
Publicado: (2015)

Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease
por: Younossi, Zobair M., et al.
Publicado: (2017)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease after Liver Transplant
por: Shetty, Akshay, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease and non-liver comorbidities
por: Manikat, Richie, et al.
Publicado: (2023)

Novel Insights into the Genetic Landscape of Nonalcoholic Fatty Liver Disease
por: Taliento, Alice Emma, et al.
Publicado: (2019)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Amjad, Waseem, et al.
Publicado: (2023)

Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease
por: Obika, Mikako, et al.
Publicado: (2012)

Nuclear Receptors in Nonalcoholic Fatty Liver Disease
por: López-Velázquez, Jorge A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_fd2eqqt4vvj9pjl95pll45k9js